Kymera Therapeutics Inc.

KYMR | NASDAQ

Price Alert Chart Builder DCF Calculator

$117.67

-$0.08 (-0.07%)

At close: Sep 21, 2026, 4:00 PM ET

$117.51

-$0.16 (-0.14%)

Pre-market: Sep 22, 2026, 7:33 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Revenue	39.2M	47.07M	78.59M	46.83M	72.83M	34.03M
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	39.2M	47.07M	78.59M	46.83M	72.83M	34.03M
Operating Income	-349.4M	-261.64M	-165.53M	-161.26M	-100.53M	-46.3M
Interest Income	38.03M	38.03M	18.76M	6.62M	488K	826K
Pretax Income	-311.62M	-223.86M	-146.96M	-154.81M	-100.22M	-45.59M
Net Income	-311.4M	-223.86M	-146.96M	-154.81M	-100.22M	-45.59M
Selling & General & Admin	68.2M	63.53M	55.04M	43.83M	36.35M	18.23M
Research & Development	316.6M	240.25M	189.08M	164.25M	137.02M	62.11M
Other Expenses	3.8M	4.93M	n/a	n/a	n/a	n/a
Operating Expenses	388.6M	308.71M	244.12M	208.08M	173.36M	80.34M
Interest Expense	249K	249K	196K	176K	175K	115K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	388.6M	308.71M	244.12M	208.08M	173.36M	80.34M
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	84.39M	75.04M	58.37M	53.93M	47.99M	44.56M
Shares Outstanding (Diluted)	84.39M	75.04M	58.37M	53.93M	47.99M	44.56M
EPS (Basic)	-3.69	-2.98	-2.52	-2.87	-2.09	-0.99
EPS (Diluted)	-3.69	-2.98	-2.52	-2.87	-2.09	-0.99
EBITDA	-303.06M	-216.24M	-143.2M	-151.66M	-97.65M	-43.72M
EBIT	-311.37M	-223.61M	-146.77M	-154.63M	-100.04M	-45.48M
Depreciation & Amortization	8.31M	7.37M	3.57M	2.98M	2.4M	1.76M